4. Did the editor or peer reviewers ask you to change or clarify the trial`s primary outcomes measure(s)? | Yes | No | Fisher’s exact test | P value |
(n = 8) | (n = 250) | |||
Type of journal | ||||
General | 3 (38%) | 115 (46%) | 0.73 | 0.46 |
Specialty | 5 (62%) | 135 (54%) | ||
Type of intervention | ||||
Drug | 2 (25%) | 125 (50%) | 0.28 | 0.15 |
Non-drug | 6 (75%) | 125 (50%) | ||
Statistical significance of primary outcome (where defined)a | ||||
Significant | 6 (86%) | 110 (48%) | 0.06 | 0.05 |
Non-significant | 1 (14%) | 121 (52%) | ||
Funding sourceb | ||||
Sole/part industry | 1 (14%) | 78 (34%) | 0.43 | 0.26 |
Non-industry | 6 (86%) | 153 (66%) | ||
5. Did the editors or peer reviewers ask you to change or clarify the statistical analysis of your primary outcome measure(s)? | Yes (n = 69) | No (n = 189) | Chi2 test | P value |
Type of journal | ||||
General | 31 (45%) | 87 (46%) | 0.02 | 0.88 |
Specialty | 38 (55%) | 102 (54%) | ||
Type of intervention | ||||
Drug | 28 (41%) | 99 (52%) | 2.82 | 0.09 |
Non-drug | 41 (59%) | 90 (48%) | ||
Statistical significance of primary outcome (where defined)a | ||||
Significant | 27 (40%) | 89 (52%) | 2.66 | 0.10 |
Non-significant | 40 (60%) | 82 (48%) | ||
Funding sourceb | ||||
Sole/part industry | 17 (26%) | 62 (36%) | 1.20 | 0.16 |
Non-industry | 48 (74%) | 111 (64%) |